Provectus Pharmaceuticals Stock Forecast

Sell candidate since Jul 13, 2026

The Provectus Pharmaceuticals, Inc stock price fell by -4.34% on the last day (Monday, 13th Jul 2026) from $0.0681 to $0.0651. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 9.22% from a day low at $0.0616 to a day high of $0.0673. The price has fallen in 6 of the last 10 days and is down by -2.84% for this period. Volume has increased on the last day by 374 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 394 thousand shares were bought and sold for approximately $25.66 thousand.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.0626 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 21.43% during the next 3 months and, with a 90% probability hold a price between $0.0761 and $0.0958 at the end of this 3-month period.

PVCT Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Provectus Pharmaceuticals, Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.0681 and $0.0656. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 14, 2026, and so far it has fallen -7.00%. Further fall is indicated until a new bottom pivot has been found. Provectus Pharmaceuticals, Inc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Provectus Pharmaceuticals, Inc stock

Provectus Pharmaceuticals, Inc finds support from accumulated volume at $0.0620 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0057 between high and low, or 9.22%. For the last week, the stock has had daily average volatility of 7.20%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PVCT) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Provectus Pharmaceuticals, Inc to open at $0.0647, and during the day (based on 14 day Average True Range), to move between $0.0632 and $0.0670, which gives a possible trading interval of +/-$0.0037 (+/-5.90%) up or down from last closing price. If Provectus Pharmaceuticals, Inc takes out the full calculated possible swing range there will be an estimated 5.90% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0652 (0.15%) than the support at $0.0620 (4.76%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Provectus Pharmaceuticals, Inc stock A Buy?

The Provectus Pharmaceuticals, Inc stock holds several negative signals and despite the positive trend, we believe Provectus Pharmaceuticals, Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Sell candidate.

Current score: -5.175 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $0.0647 ( 0.676%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk